(h) INDIAN
HEALTH
SERVICE
TESTING, MONI-
TORING, AND PRESCRIPTION DRUGS FOR THE PREVEN-
TION OF HIV ACQUISITION.—The Indian Health Care Im-
provement Act is amended by inserting after section 223 
(25 U.S.C. 1621v) the following: 
‘‘SEC. 224. TESTING, MONITORING, AND PRESCRIPTION 
DRUGS FOR THE PREVENTION OF HIV ACQUI-
SITION. 
‘‘(a) IN GENERAL.—The Secretary, acting through 
the Service, Indian tribes, and tribal organizations, shall 
provide funding for any prescription drug approved by the 
Food and Drug Administration for the prevention of HIV 
acquisition, laboratory and other diagnostic procedures as-
sociated with the use of such drugs, and clinical follow 
up and monitoring, including any related services rec-
ommended in current United States Public Health Service 
clinical practice guidelines, without limitation. 
‘‘(b) AUTHORIZATION OF APPROPRIATIONS.—There 
are authorized to be appropriated to carry out this section 
such sums as may be necessary.’’. 
(i) EFFECTIVE DATE.—The amendments made by 
subsections (a), (b), (e), (f), (g), and (h) shall take effect 
with respect to plan years beginning on or after January 
1, 2021. 
VerDate Sep 11 2014 
04:29 Aug 01, 2019
Jkt 089200
PO 00000
Frm 00018
Fmt 6652
Sfmt 6201
E:\BILLS\H3815.IH
H3815
kjohnson on DSK79L0C42 with BILLS
SEC. 4. PROHIBITION ON DENIAL OF COVERAGE OR IN-
CREASE IN PREMIUMS OF LIFE, DISABILITY, 
OR LONG-TERM CARE INSURANCE FOR INDI-
VIDUALS TAKING MEDICATION FOR THE PRE-
VENTION OF HIV ACQUISITION. 
(a) PROHIBITION.—Notwithstanding any other provi-
sion of law, it shall be unlawful to— 
(1) decline or limit coverage of a person under 
any life insurance policy, disability insurance policy, 
or long-term care insurance policy, on account of the 
individual taking medication for the purpose of pre-
venting the acquisition of HIV; 
(2) preclude an individual from taking medica-
tion for the purpose of preventing the acquisition of 
HIV as a condition of receiving a life insurance pol-
icy, disability insurance policy, or long-term care in-
surance policy; 
(3) consider whether an individual is taking 
medication for the purpose of preventing the acquisi-
tion of HIV in determining the premium rate for 
coverage of such individual under a life insurance 
policy, disability insurance policy, or long-term care 
insurance policy; or 
(4) otherwise discriminate in the offering, 
issuance, cancellation, amount of such coverage, 
price, or any other condition of a life insurance pol-
VerDate Sep 11 2014 
04:29 Aug 01, 2019
Jkt 089200
PO 00000
Frm 00019
Fmt 6652
Sfmt 6201
E:\BILLS\H3815.IH
H3815
kjohnson on DSK79L0C42 with BILLS
icy, disability insurance policy, or long-term care in-
surance policy for an individual, based solely and 
without any additional actuarial risks upon whether 
the individual is taking medication for the purpose 
of preventing the acquisition of HIV. 
(b) ENFORCEMENT.—A State insurance regulator 
may take such actions to enforce subsection (a) as are spe-
cifically authorized under the laws of such State. 
(c) DEFINITIONS.—In this section: 
(1) DISABILITY INSURANCE POLICY.—The term 
‘‘disability insurance policy’’ means a contract under 
which an entity promises to pay a person a sum of 
money in the event that an illness or injury resulting 
in a disability prevents such person from working. 
(2) LIFE INSURANCE POLICY.—The term ‘‘life 
insurance policy’’ means a contract under which an 
entity promises to pay a designated beneficiary a 
sum of money upon the death of the insured. 
(3) LONG-TERM
CARE
INSURANCE
POLICY.— 
The term ‘‘long-term care insurance policy’’ means 
a contract for which the only insurance protection 
provided under the contract is coverage of qualified 
long-term care services (as defined in section 
7702B(c) of the Internal Revenue Code of 1986). 
VerDate Sep 11 2014 
04:29 Aug 01, 2019
Jkt 089200
PO 00000
Frm 00020
Fmt 6652
Sfmt 6201
E:\BILLS\H3815.IH
H3815
kjohnson on DSK79L0C42 with BILLS
SEC. 5. PUBLIC EDUCATION CAMPAIGN. 
Part P of title III of the Public Health Service Act 
(42 U.S.C. 280g et seq.) is amended by adding at the end 
the following: 
‘‘SEC. 399V–7. PRE-EXPOSURE PROPHYLAXIS PUBLIC EDU-
CATION CAMPAIGN. 
‘‘(a) IN GENERAL.—The Secretary, acting through 
the Director of the Centers for Disease Control and Pre-
vention, shall establish a public health campaign for the 
purpose of educating the public on medication for the pre-
vention of HIV acquisition. 
‘‘(b) REQUIREMENTS.—In carrying out this section, 
the Secretary shall ensure cultural competency and effi-
cacy within high-need communities in which PrEP is un-
derutilized by developing the campaign in collaboration 
with organizations that are indigenous to communities 
that are overrepresented in the domestic HIV epidemic, 
including communities of color and the lesbian, gay, bisex-
ual, transgender, and queer community. The Secretary 
shall ensure that the campaign is designed to increase 
awareness of the safety and effectiveness of PrEP, the rec-
ommended clinical practices for providing PrEP-related 
clinical care, and the local availability of PrEP providers, 
and to counter stigma associated with the use of PrEP. 
‘‘(c) EVALUATION
OF PROGRAM.—The Secretary 
shall develop measures to evaluate the effectiveness of ac-
VerDate Sep 11 2014 
04:29 Aug 01, 2019
Jkt 089200
PO 00000
Frm 00021
Fmt 6652
Sfmt 6201
E:\BILLS\H3815.IH
H3815
kjohnson on DSK79L0C42 with BILLS
tivities conducted under this section that are aimed at re-
ducing disparities in access to PrEP and supporting the 
local community. Such measures shall evaluate community 
outreach activities, language services, workforce cultural 
competence, and other areas as determined by the Sec-
retary. 
‘‘(d) PREP.—In this section, the term ‘PrEP’ means 
any drug approved by the Food and Drug Administration 
for the purpose of pre-exposure prophylaxis with respect 
to HIV. 
‘‘(e) AUTHORIZATION OF APPROPRIATIONS.—There 
are authorized to be appropriated such sums as may be 
necessary for each of fiscal years 2021 through 2026.’’. 
SEC. 6. PATIENT CONFIDENTIALITY. 
The Secretary of Health and Human Services shall 
amend the regulations promulgated under section 264(c) 
of the Health Insurance Portability and Accountability 
Act of 1996 (42 U.S.C. 1320d–2 note), as necessary, to 
ensure that individuals are able to access the benefits de-
scribed in section 2713(a)(6) under a family plan without 
any other individual enrolled in such family plan, including 
a primary subscriber of or policyholder, being informed of 
such use of such benefits. 
VerDate Sep 11 2014 
04:29 Aug 01, 2019
Jkt 089200
PO 00000
Frm 00022
Fmt 6652
Sfmt 6201
E:\BILLS\H3815.IH
H3815
kjohnson on DSK79L0C42 with BILLS